{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:28:11Z","timestamp":1795120091584,"version":"4.10.3"},"reference-count":20,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":80,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[2001,10]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Tumor\u2010infiltrating lymphocytes (TILs) are considered to play an important role in the antitumoral immune response. The presence and percentage of CD8\u2010positive tumor\u2010infiltrating T cells have been shown to correlate with differentiation and prognosis in various neoplasms. The aim of this study was to determine the number of CD8\u2010positive T cells in various primary cutaneous B\u2010cell lymphoproliferative disorders and to evaluate its correlation with the histological type of tumor.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Fifty\u2010three lesions were examined by immunohistochemistry with antibodies targeting CD3, CD4, CD8 and TIA\u20101. Thirty\u2010two lesions had been diagnosed as primary cutaneous B\u2010cell lymphomas (CBCL) and 21 as B\u2010cell pseudolymphomas (B\u2010PSL). CBCLs included 15 follicular lymphomas (FL), 6 marginal zone lymphomas (MZL), and 11 diffuse large B\u2010cell lymphomas (LCL). The number of CD8\u2010positive cytotoxic T cells was determined by computer\u2010assisted morphometrical microscopy.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> No significant difference could be detected in the density of CD8\u2010positive T cells in B\u2010PSL (101\/10<jats:sup>5<\/jats:sup>\u03bcm<jats:sup>2<\/jats:sup>), FL (110\/10<jats:sup>5<\/jats:sup>\u03bcm<jats:sup>2<\/jats:sup>), and MZL (122\/10<jats:sup>5<\/jats:sup>\u03bcm<jats:sup>2<\/jats:sup>). In contrast, the number of CD8\u2010positive cells (55\/10<jats:sup>5<\/jats:sup>\u03bcm<jats:sup>2<\/jats:sup>) in LCL was significantly lower (p&amp;lt;0.01) compared to B\u2010PSL, FL and MZL.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> In summary the number of CD8\u2010positive T cells in B\u2010cell lymphoproliferative disorders differs in regard to tumor type and differentiation with lowest numbers in diffuse large B\u2010cell lymphomas. However, due to an overlap of the number of TILs, this parameter cannot be employed as a diagnostic parameter for individual cases.<\/jats:p>","DOI":"10.1034\/j.1600-0560.2001.028009448.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T13:54:25Z","timestamp":1047390865000},"page":"448-452","source":"Crossref","is-referenced-by-count":9,"title":["Tumor\u2010infiltrating T cells in primary cutaneous B\u2010cell lympho\u2010proliferative disorders"],"prefix":"10.1111","volume":"28","author":[{"given":"Jivko","family":"Kamarashev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Schaerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hess Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-0486(97)80009-9"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30188-8"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890350042008"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(89)90362-6"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<492::AID-IJC3>3.0.CO;2-Z"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270214"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90067-5"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1182\/blood.V89.4.1376","article-title":"Activated cytotoxic T cells as prognostic marker in Hodgkin\u2019s disease","volume":"89","author":"Oudejans JJ","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90536-8"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-200004000-00009"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709068281"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05204.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ajcp\/101.4.413","article-title":"Heterogeneity of neoplastic and reactive cell proliferation in non\u2010Hodgkin\u2019s lymphomas linked to patient survival","volume":"101","author":"French M","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1984.tb00904.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1983.tb04592.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050199"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.4049\/jimmunol.155.3.1382","article-title":"T cells infiltrating non\u2010Hodgkin\u2019s B\u2010cell lymphomas show altered tyrosine phosphorylation pattern even though T\u2010cell receptor\/CD3\u2010associated kinases are present","volume":"155","author":"Wang Q","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5291.1363"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1069(199708)15:3<129::AID-HON607>3.3.CO;2-E"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0196-52"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0560.2001.028009448.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0560.2001.028009448.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0560.2001.028009448.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T21:42:04Z","timestamp":1697492524000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0560.2001.028009448.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["10.1034\/j.1600-0560.2001.028009448.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0560.2001.028009448.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}